BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23716545)

  • 1. Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.
    Van Wier S; Braggio E; Baker A; Ahmann G; Levy J; Carpten JD; Fonseca R
    Haematologica; 2013 Oct; 98(10):1586-92. PubMed ID: 23716545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional-structural-chromosomal aberrations are associated with inferior clinical outcome in patients with hyperdiploid multiple myeloma: a single-institution experience.
    Carballo-Zarate AA; Medeiros LJ; Fang L; Shah JJ; Weber DM; Thomas SK; Manasanch EE; Hao S; Shen Q; Orlowski RZ; Lin P; Lu X
    Mod Pathol; 2017 Jun; 30(6):843-853. PubMed ID: 28281554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
    Sawyer JR
    Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotype and DNA content of myeloma cells in primary plasma cell leukemia.
    Shimazaki C; Gotoh H; Ashihara E; Oku N; Inaba T; Murakami S; Itoh K; Ura Y; Nakagawa M; Fujita N
    Am J Hematol; 1992 Mar; 39(3):159-62. PubMed ID: 1546712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma?
    Greipp PR; Trendle MC; Leong T; Oken MM; Kay NE; Van Ness B; Kyle RA
    Leuk Lymphoma; 1999 Sep; 35(1-2):83-9. PubMed ID: 10512165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypodiploidy is a major prognostic factor in multiple myeloma.
    Smadja NV; Bastard C; Brigaudeau C; Leroux D; Fruchart C;
    Blood; 2001 Oct; 98(7):2229-38. PubMed ID: 11568011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
    Carroll AJ; Shago M; Mikhail FM; Raimondi SC; Hirsch BA; Loh ML; Raetz EA; Borowitz MJ; Wood BL; Maloney KW; Mattano LA; Larsen EC; Gastier-Foster J; Stonerock E; Ell D; Kahwash S; Devidas M; Harvey RC; Chen IL; Willman CL; Hunger SP; Winick NJ; Carroll WL; Rao KW; Heerema NA
    Cancer Genet; 2019 Oct; 238():62-68. PubMed ID: 31425927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
    Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
    Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
    Li X; Pennisi A; Zhan F; Sawyer JR; Shaughnessy JD; Yaccoby S
    Br J Haematol; 2007 Sep; 138(6):802-11. PubMed ID: 17760811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of G banded karyotypes in myeloma cells.
    Chen KC; Bevan PC; Matthews JG
    J Clin Pathol; 1986 Mar; 39(3):260-6. PubMed ID: 3457025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Song S; Zhang J; Su Q; Zhang W; Jiang Y; Fan G; Qian C; Li B; Zhuang W
    Br J Cancer; 2021 May; 124(11):1843-1853. PubMed ID: 33785876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shaping and functional consequences of the dosage effect landscape in multiple myeloma.
    Samur MK; Shah PK; Wang X; Minvielle S; Magrangeas F; Avet-Loiseau H; Munshi NC; Li C
    BMC Genomics; 2013 Oct; 14():672. PubMed ID: 24088394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
    Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
    Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenetic abnormalities in high-risk multiple myeloma].
    Ishida T
    Nihon Rinsho; 2015 Jan; 73(1):28-32. PubMed ID: 25626299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
    Barilà G; Bonaldi L; Grassi A; Martines A; Liço A; Macrì N; Nalio S; Pavan L; Berno T; Branca A; Calabretto G; Carrino M; Teramo A; Manni S; Piazza F; Semenzato G; Zambello R
    Blood Cancer J; 2020 Feb; 10(2):18. PubMed ID: 32066724
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background.
    Rojas EA; Corchete LA; Mateos MV; García-Sanz R; Misiewicz-Krzeminska I; Gutiérrez NC
    Blood Cancer J; 2019 Nov; 9(12):90. PubMed ID: 31748515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.